Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population

被引:16
作者
Saarikoski, ST
Suitiala, T
Holmila, R
Impivaara, O
Järvisalo, J
Hirvonen, A
Husgafvel-Pursiainen, K
机构
[1] Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, FI-00250 Helsinki, Finland
[2] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, FI-20720 Turku, Finland
[3] Social Insurance Inst, FI-20720 Turku, Finland
基金
芬兰科学院;
关键词
genetic polymorphism; CYP2S1; SNP; allele; haplotype; carcinogen metabolism;
D O I
10.1016/j.mrfmmm.2004.05.007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CYP2S1 is a recently discovered member of the cytochrome P450 (CYP) gene superfamily. Interestingly, even though the DNA sequence identifies it as the sole member of the new CYP2S family, CYP2S1 exhibits many features typical to CYP1 family members, e.g. dioxin-inducibility mediated by the aryl hydrocarbon receptor (AHR) and the aryl hydrocarbon receptor nuclear translocator (ARNT). In addition, CYP2S1 metabolises some aromatic hydrocarbons as well as cellular substances. These characteristics, together with a wide extrahepatic tissue distribution, suggest that CYP2S1 may have an important role in both exogenous and endogenous metabolism. This is the first study characterising CYP2S1 alleles and naming them with the recommended CYP allele nomenclature. We used denaturing gradient gel electrophoresis (DGGE) and direct sequencing to investigate genetic variation of CYP2S1 in 100 male Finnish Caucasians. Those exons in which variation was found were examined in subsequent 100 subjects. The coding region of all of the nine exons, as well as a 449 bp fragment of the proximal promoter region, was analysed. This systematic investigation revealed eight single nucleotide polymorphisms (SNPs), which comprise nine different variant alleles (haplotypes), in addition to the wild-type allele. Seven of the SNPs occurred in the protein-coding areas and one in the proximal 3' untranslated region (3'UTR). Two of these sequence variations (10347C > T and 13106C > T) result in non-conservative amino acid substitutions, i.e. Arg'10Cys and Pro466 Leu, respectively. The respective allelic variants, CYP2S1*2 ([10347C > T]) and CYP2S1*3 (13106C > T; 13255A > G]), occurred in our study population at frequencies of 0.50 and 3.75%, respectively. The most common of the variant alleles was CYP2S1*1H (23.8%), harbouring a 13255A > G substitution located in the 3'UTR. (C) 2004 Elsevier B.V. All fights reserved.
引用
收藏
页码:267 / 277
页数:11
相关论文
共 33 条
[1]  
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[2]  
Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3
[3]   Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues [J].
Choudhary, D ;
Jansson, I ;
Schenkman, JB ;
Sarfarazi, M ;
Stoilov, I .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 414 (01) :91-100
[4]   Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts [J].
Ding, XX ;
Kaminsky, LS .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :149-173
[5]   The sensitivity of denaturing gradient gel electrophoresis: A blinded analysis [J].
Gejman, PV ;
Cao, QH ;
Guedj, F ;
Sommer, S .
MUTATION RESEARCH-GENOMICS, 1998, 382 (3-4) :109-114
[6]   Identification of a 43-kDa protein in human liver cytosol that binds to the 3′-untranslated region of CYP2A6 mRNA [J].
Gilmore, J ;
Rotondo, F ;
Pelletier, AM ;
LaMarre, J ;
Alaoui-Jamali, M ;
Kirby, GM .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (06) :669-678
[7]  
GOTOH O, 1992, J BIOL CHEM, V267, P83
[8]   Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19 [J].
Hoffman, SMG ;
Nelson, DR ;
Keeney, DS .
PHARMACOGENETICS, 2001, 11 (08) :687-698
[9]   Lung cancer and past occupational exposure to asbestos -: Role of p53 and K-ras mutations [J].
Husgafvel-Pursiainen, K ;
Karjalainen, A ;
Kannio, A ;
Anttila, S ;
Partanen, T ;
Ojajärvi, A ;
Vainio, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) :667-674
[10]  
Husgafvel-Pursiainen K, 2000, CANCER RES, V60, P2906